Home Newsfeeds Keybanc Maintains Overweight on Smartsheet, Raises Price Target to $48

Keybanc Maintains Overweight on Smartsheet, Raises Price Target to $48

Keybanc analyst Jason Celino maintains Smartsheet (NYSE:SMAR) with a Overweight and raises the price target from $46 to $48.

byBenzinga Newsdesk

March 1, 2023

1 minute read

Keybanc analyst Jason Celino maintains Smartsheet (NYSE:SMAR) with a Overweight and raises the price target from $46 to $48.

Amgen Responds To FTC Action Re: Proposed Acquisition Of Horizon Therapeutics; Says Disappointed By The FTC’s Decision And Remains Committed To Completing This Acquisition

By Happy Mohamed

May 16, 11:32 AM

Amgen (NASDAQ:AMGN) today issued the following statement in response to the U.S. Federal Trade Commission's (FTC) complaint seeking to block the company's proposed acquisition of Horizon Therapeutics

AMGN

Ethereum Co-Creator Vitalik Buterin’s X Account Reportedly Breached, Hacker Makes Away With $690K+

By Benzinga Neuro

September 11, 4:27 AM

The X account of Ethereum (CRYPTO: ETH) founder, Vitalik Buterin, was hacked, leading to a theft of over $690,000 from users who were lured into clicking a deceptive link.

ETH

Japanese Government Urges China To Release Astellas Pharma’s Employee

By Vandana Singh

March 27, 7:34 AM

The Japanese government is reportedly seeking the release of an employee of Japanese pharma company Astellas Pharma Inc (OTC: ALPMF), detained by Chinese authorities. The reasons why the person was detained are still unknown.

ALPMF

Ares Commercial Real: Q2 Earnings Insights

By Benzinga Insights

July 29, 6:53 AM

Ares Commercial Real (NYSE:ACRE) reported its Q2 earnings results on Friday, July 29, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

ACRE

Keybanc Maintains Overweight on Smartsheet, Raises Price Target to $48

Related Posts

Amgen Responds To FTC Action Re: Proposed Acquisition Of Horizon Therapeutics; Says Disappointed By The FTC’s Decision And Remains Committed To Completing This Acquisition

Ethereum Co-Creator Vitalik Buterin’s X Account Reportedly Breached, Hacker Makes Away With $690K+

Japanese Government Urges China To Release Astellas Pharma’s Employee

Ares Commercial Real: Q2 Earnings Insights